Psivant Therapeutics
Vishal Sindhava is currently the Director of Biology at Psivant Therapeutics. Prior to this, Vishal held roles as Principal Investigator at Roivant Sciences, Senior Scientist in Immuno-Oncology at Servier Pharmaceuticals, and various positions at Agios Pharmaceuticals. Vishal's educational background includes a Ph.D. in Immunology from the University of Kentucky.
Psivant Therapeutics
Psivant Therapeutics is advancing a paradigm shift in biotechnology by pioneering a physics-driven approach to drug design that is tightly coupled to chemistry and biology research and development. Our QUAISAR platform is purpose-built to develop novel small molecule therapeutics to address biologically and genetically validated, but previously intractable, protein targets.